Advertisement

Clinical Implications of Retroperitoneal Sarcomas

  • Dionysis C. Voros
  • Theodosios C. Theodosopoulos
Chapter

Abstract

RPS account for approximately one-third of all retroperitoneal masses. Differential diagnosis, including lymphoma, testicular neoplasm, germ cell tumor, desmoids, functioning and nonfunctioning adrenal masses, renal tumor, pancreatic tumor, and gastrointestinal stromal tumor, should be considered. If visceral invasion is present, the differential should include tumors of these organs, and endoscopy with biopsy, if feasible, to evaluate for intraluminal evidence of involvement (e.g., stomach, duodenum, pancreas, colon), should be performed.

References

  1. 1.
    Caudle AS, Delman KA, Cormier JN (2012) Soft tissue and bone sarcoma. In: Feig BW, Denise Ching C (eds) The MD Anderson surgical oncology. Handbook, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 127–149Google Scholar
  2. 2.
    Sandrucci S, Stacchiotti S, Gronchi A (2017) Retroperitoneal sarcoma. In: Poston G, Wyld L, Audisio RA (eds) Surgical oncology theory and multidisciplinary practice, 2nd edn. ESSO. CRC Press Taylor & Francis Group, Boca Raton, pp 617–629Google Scholar
  3. 3.
    Aufforth RD, Baker JJ, Kim HJ (2015) Soft tissue sarcoma. In: Chu QD, Gibbs JF, Zibari GZ (eds) Surgical oncology. A practical and comprehensive approach. Springer, New York, pp 605–626Google Scholar
  4. 4.
    Voros D, Theodorou D, Ventouri K, Prachalias A, Danias N, Gouliamos A (1998) Retroperitoneal tumors: do the satellite tumors mean something? J Surg Oncol 68:30–33CrossRefGoogle Scholar
  5. 5.
    Stoeckle E, Coindre JM, Bonvalot S et al (2001) Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 92:359–368CrossRefGoogle Scholar
  6. 6.
    Anaya DA, Lahat G, Liu J, Xing Y, Cormier JN, Pisters PW, Lev DC, Pollock RE (2009) Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg 249(1):137–142CrossRefGoogle Scholar
  7. 7.
    Porpiglia A, Reddy SS, Farma JM (2016) Retroperitoneal sarcomas. Surg Clin N Am 96:993–1001CrossRefGoogle Scholar
  8. 8.
    Karakousis CP, Gerstenbluth R, Kontzoglou K et al (1995) Retroperitoneal sarcomas and their management. Arch Surg 130:1104–1109CrossRefGoogle Scholar
  9. 9.
    Karakousis CP (2010) Refinements of surgical technique in soft tissue sarcomas. J Surg Oncol 101:730–738CrossRefGoogle Scholar
  10. 10.
    Theodosopoulos T, Psychogiou V, Yiallourou AI, Polymeneas G, Kondi-Pafiti A, Papaconstantinou I, Voros D (2012) Management of retroperitoneal sarcomas: main prognostic factors for local recurrence and survival. J BUON 17:138–142PubMedGoogle Scholar
  11. 11.
    Theodosopoulos T, Stafyla VK, Tsiantoula P, Yiallourou A, Marinis A, Kondi-Pafiti A, Chatziioannou A, Boviatsis E, Voros D (2008) Special problems en-countering surgical management of large retroperitoneal schwannomas. World J Surg Oncol 6:107CrossRefGoogle Scholar
  12. 12.
    Voros D, Kyriazi M, Anastasopoulos G, Drakopoulou S, Kairi E, Michalaki V. Vena cava resection en bloc with retroperitoneal liposarcoma. 36th Congress of ESSO 2016, Krakow, PolandGoogle Scholar
  13. 13.
    Keung EZ, Fairweather M, Raut CP (2016) Surgical management of metastatic disease. Surg Clin N Am 96:1175–1192CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Dionysis C. Voros
    • 1
  • Theodosios C. Theodosopoulos
    • 1
  1. 1.Second Department of Surgery, Aretaieion Hospital, Athens Medical SchoolAthens UniversityAthensGreece

Personalised recommendations